These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 15858865)

  • 1. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Perron R
    Neurology; 2005 Apr; 64(8):1485-6; author reply 1485-6; discussion 1485-6. PubMed ID: 15858865
    [No Abstract]   [Full Text] [Related]  

  • 2. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Jefferys RJ
    Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16116145
    [No Abstract]   [Full Text] [Related]  

  • 3. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Wiberg CC
    Neurology; 2005 Apr; 64(8):1485-6; author reply 1485-6; discussion 1485-6. PubMed ID: 15851759
    [No Abstract]   [Full Text] [Related]  

  • 4. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Sherry JH; Bechtel T
    Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16118859
    [No Abstract]   [Full Text] [Related]  

  • 5. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Stetz SA
    Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16118861
    [No Abstract]   [Full Text] [Related]  

  • 6. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Rackley RJ
    Neurology; 2005 Aug; 65(4):657-8; author reply 657-8. PubMed ID: 16118860
    [No Abstract]   [Full Text] [Related]  

  • 7. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Burkhardt RT; Leppik IE; Blesi K; Scott S; Gapany SR; Cloyd JC
    Neurology; 2004 Oct; 63(8):1494-6. PubMed ID: 15505173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generic anticonvulsant use in children: do we have evidence to recommend brand formulations?
    Hamiwka LD
    Arch Neurol; 2009 Nov; 66(11):1417-8. PubMed ID: 19901177
    [No Abstract]   [Full Text] [Related]  

  • 9. The value of specifying brand-name antiepileptic drugs.
    Ng YT
    Arch Neurol; 2009 Nov; 66(11):1415-6. PubMed ID: 19901176
    [No Abstract]   [Full Text] [Related]  

  • 10. Generic substitution in the treatment of epilepsy: case evidence of breakthrough seizures.
    Berg MJ; Gross RA; Tomaszewski KJ; Zingaro WM; Haskins LS
    Neurology; 2008 Aug; 71(7):525-30. PubMed ID: 18695164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's the problem with generic antiepileptic drugs?: a call to action.
    Berg MJ
    Neurology; 2007 Apr; 68(16):1245-6. PubMed ID: 17438211
    [No Abstract]   [Full Text] [Related]  

  • 12. Generic prescribing in epilepsy.
    Drug Ther Bull; 2009 Dec; 47(12):141-4. PubMed ID: 20009042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is bioavailability altered in generic versus brand anticonvulsants?
    Jankovic SM; Ignjatovic Ristic D
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):329-32. PubMed ID: 25440299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes associated with brand-to-generic phenytoin interchange.
    Kinikar SA; Delate T; Menaker-Wiener CM; Bentley WH
    Ann Pharmacother; 2012 May; 46(5):650-8. PubMed ID: 22550275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economic implications of generic substitution of antiepileptic drugs: a review of recent evidence.
    Duh MS; Cahill KE; Paradis PE; Cremieux PY; Greenberg PE
    Expert Opin Pharmacother; 2009 Oct; 10(14):2317-28. PubMed ID: 19663636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
    Argumosa A; Herranz JL
    Rev Neurol; 2005 Jul 1-15; 41(1):45-9. PubMed ID: 15999330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are generic drugs really inferior medicines?
    Moore N; Berdaï D; Bégaud B
    Clin Pharmacol Ther; 2010 Sep; 88(3):302-4. PubMed ID: 20725079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analogs of generic preparations for the treatment of epilepsy: is their use safe?].
    Crawford P; Hall W; Chappell V; Collings J; Stewart A
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(10):29-31. PubMed ID: 11712265
    [No Abstract]   [Full Text] [Related]  

  • 19. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE; Tomson T
    Epilepsia; 2008 Dec; 49 Suppl 9():56-62. PubMed ID: 19087118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
    Berg MJ; Gross RA; Haskins LS; Zingaro WM; Tomaszewski KJ
    Epilepsy Behav; 2008 Nov; 13(4):693-9. PubMed ID: 18589000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.